Concepedia

Amruta Indapurkar

AI

Statistics

Publications

5

Citations

156

H-Index

5

Active since

2013

Affiliations

Mercer University Health Sciences Center(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

Mercer University

Amruta Indapurkar is an author at Mercer University Health Sciences Center specializing in pharmacy, toxicology, and clinical toxicology.

ORCID

Publications per year

2013–2022

5

Publications

5

Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation

Andrés M. Rubiano, Amruta Indapurkar, Ryosuke Yokosawa et al. · Clinical and Translational Science · 2020 · 93 citations · Full text

, , +17

Evaluation of Triazole-Chelated Lanthanides as Chemically Stabile Bioimaging Agents

Amruta Indapurkar, Brian Henriksen, Justin A. Tolman et al. · Journal of Pharmaceutical Sciences · 2013 · 23 citations

, , +10

Multiplexed ELISA screening assay for nine paralytic shellfish toxins in human plasma

Padmanabhan Eangoor, Amruta Indapurkar, Mani Deepika Vakkalanka et al. · The Analyst · 2019 · 17 citations

, , +14

Rapid and Sensitive ELISA Screening Assay for Several Paralytic Shellfish Toxins in Human Urine

Padmanabhan Eangoor, Amruta Indapurkar, Manideepika Vakkalanka et al. · Journal of Analytical Toxicology · 2017 · 13 citations · Full text

, , +15

hERG block potencies for 5 positive control drugs obtained per ICH E14/S7B Q&As best practices: Impact of recording temperature and drug loss

Claudia Alvarez Baron, Nicolas Thiebaud, Ming Ren et al. · Journal of Pharmacological and Toxicological Methods · 2022 · 10 citations · Full text

, , +15

1–5 of 5